The Mississippi State Department of Health has announced the initiation of a “mass re-testing” of certain cannabis products that were previously removed from dispensaries last month. The Mississippi Medical Cannabis Program (MSDH) took these products off the shelves on December 21 after discovering discrepancies during an audit of Certificates of Analysis concerning original test results for pesticides and mycotoxins conducted by Rapid Analytics.
Re-Testing Process and Timeline
According to a Thursday news release from MSDH, the re-testing process is anticipated to take two to three weeks. Cleared batches of products will be made available each Friday until the process is complete. The initial focus will be on flower and bud, as they form the basis for many other products. Testing for concentrates and infused products will follow. The Mississippi Medical Cannabis Program will cover the expenses associated with all re-testing efforts.
Commitment to Patient Safety
“Patient safety is our top priority,” asserted Laura Goodson, director of the Mississippi Medical Cannabis Program. She emphasized the importance of ensuring that all test results comply with regulatory standards, thereby making approved products accessible to those participating in the medical cannabis program. An ongoing investigation continues to address the reported discrepancies.
Patients are encouraged to reach out to their local dispensaries to check on the availability of products as this re-testing unfolds.
